Distributing the Expanding Assortment of Specialty Pharmaceuticals with Jeff Beck BioCareSD TRANSCRIPT
Download PDFAug 14, 2022
Jeff Beck is the Chief Development Officer at BioCareSD, a specialty pharmaceutical distributor. The field of specialty drugs has grown from the first drug for hemophilia in the 1980s to today, with about 50% of the drugs in the pipeline being specialty drugs. BioCareSD is an important component of the supply chain to...
Aug 14, 2022
Jeff Beck is the Chief Development Officer at BioCareSD, a specialty pharmaceutical distributor. The field of specialty drugs has grown from the first drug for hemophilia in the 1980s to today, with about 50% of the drugs in the pipeline being specialty drugs. BioCareSD is an important component of the supply chain to...
Treating Inflammatory Diseases by Blocking Neutrophils Moving from Bone Marrow with James Mackay Aristea Therapeutics TRANSCRIPT
Download PDFAug 2, 2022
James Mackay is the Founder, President, and CEO of Aristea Therapeutics, a San Diego-based company that is applying its insights on neutrophils to develop a treatment for a rare inflammatory skin condition known as palmoplantar pustulosis, PPP. Most of the people who get this disease are postmenopausal females, and...
Aug 2, 2022
James Mackay is the Founder, President, and CEO of Aristea Therapeutics, a San Diego-based company that is applying its insights on neutrophils to develop a treatment for a rare inflammatory skin condition known as palmoplantar pustulosis, PPP. Most of the people who get this disease are postmenopausal females, and...
Jun 27, 2022
Javier Szwarcberg, CEO of Spruce Biosciences, is developing a compound to address the needs of patients with classic congenital adrenal hyperplasia, CAH, a rare disease first diagnosed at birth. Only recently have companies started to explore innovative therapies to improve the standard of care discovered in the early...